发明名称 7alpha-(ξ-AMINOALKYL)ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7alpha-(ξ-AMINOALKYL)ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENTS
摘要 1. Substituted 7&alpha;-(&xi;-aminoalkyl)estratrienes of general formula I in which side chain SK is a radical of partial formula whereby m is 4, 5 or 6, n is 0, 1 or 2, x is 0, 1 or 2, A is a hydrogen atom or a C1-C5 alkyl group, B and D each are a hydrogen atom, or A and B together are an alkylene group -(CH2)p- wherein p=2, 3, 4 or 5, and D is a hydrogen atom or A and D together are an alkylene group -(CH2)q- wherein q=2, 3 or 4, and B is a hydrogen atom, and E is an unsubstituted ethyl radical or an ethyl radical that is fluorinated in one to five places, or terminal substituent -(CH2)3-E in the side chain is replaced by an optionally substituted aryl or heteroaryl radical, which is bonded directly or via a mono-, di- or trimethylene group to the sulfur atom, R<3> is a hydrogen atom, a hydrocarbon radical with up to 8 carbon atoms or a radical of formula R<3>'-C(O)-, in which R<3>' is a hydrogen atom or a hydrocarbon radical with up to 8 carbon atoms or a phenyl radical, R<11> is a hydrogen atom, a halogen atom or a nitrooxy group -O-NO2, R<14>, R<15&alpha;>, R<15&beta;>, R<16&alpha;> and R<16&beta;> each are a hydrogen atom or R<14> and R<15&alpha;> are an additional bond or a methylene bridge, or R<15&beta;> is a methyl group and R<15&alpha;> is a hydrogen atom, or R<15&alpha;> and R<15&beta;> in each case are a methyl group, or R<15&beta;> and R<16&beta;> together are a methylene bridge, or R<16&alpha;> or R<16&beta;> is a halogen atom or R<16&alpha;> and R<16&beta;> together are a methylidene group and the remaining substituents R<14>, R<15&alpha;>, R<15&beta;>, R<16&alpha;> and R<16&beta;> are each a hydrogen atom, R<17>' in &alpha;- or &beta;-position is a hydrogen atom, a C1-C5 alkyl, C2-C5 alkenyl or C2-C5 alkinyl group or a trifluoromethyl group and R<17>'' is a hydrogen atom or a radical of partial formula R<17>''' -C(O)-, in which R<17>''' is a hydrogen atom or a hydrocarbon radical with up to 8 carbon atoms, or, if R<17>' is in &alpha;- position, R<17>' together with R<14> means an ethano bridge, provided that if A and B together are not -(CH2)p- or A and D together are not -(CH2)q-, at least one of substituents R<11>, R<14>, R<15&alpha;>, R<15&beta;>, R<16&alpha;> and R<16&beta;> is not a hydrogen atom, as well as their physiologically compatible addition salts with organic and inorganic acids. 2. Estratrienes according to Claim 1, in which m is 5. 3. Estratrienes according to Claim 1, in which n is 0. 4. Estratrienes according to Claim 1, in which n is 1. 5. Estratrienes according to Claim 1, in which n is 2. 6. Estratrienes according to Claim 1, in which A is a methyl group. 7. Estratrienes according to Claim 1, in which x is 0. 8. Estratrienes according to Claim 1, in which x is 1. 9. Estratrienes according to Claim 1, in which x is 2. 10. Estratrienes according to Claim 6, in which n is 1. 11. Estratrienes according to Claim 1, in which A and B together are -(CH2)3-. 12. Estratrienes according to Claim 11, in which n is 0. 13. Estratrienes according to Claim 12, in which x is 0. 14. Estratrienes according to Claim 1, in which E is a perfluoroethyl radical. 15. Estratrienes according to Claim 1, in which R<3> is a hydrogen atom. 16. Estratrienes according to Claim 1, in which R<3> is a methyl group. 17. Estratrienes according to Claim 1, in which R<3> is an acetyl group. 18. Estratrienes according to Claim 1, in which R<11> is a hydrogen atom. 19. Estratrienes according to Claim 1, in which R<11> is a fluorine atom. 20. Estratrienes according to Claim 1, in which R<11> is a nitrooxy group. 21. Estratrienes according to Claim 1, in which R<14> is a hydrogen atom. 22. Estratrienes according to Claim 1, in which R<14> together with R<15&alpha;> forms an additional bond. 23. Estratrienes according to Claim 1, in which R<15&beta;> is a methyl group. 24. Estratrienes according to Claim 1, in which R<15&beta;> and R<16&beta;> together form a methylene bridge. 25. Estratrienes according to Claim 1, in which R<16&alpha;> is a halogen atom (F, Cl, Br, I). 26. Estratrienes according to Claim 25, in which R<16&alpha;> is a fluorine atom. 27. Estratrienes according to Claim 1, in which R<16&alpha;> and R<16&beta;> together form a methylidene group. 28. Estratrienes according to Claim 1, in which R<17> is in &alpha;-position. 29. Estratrienes according to Claim 28, in which R<17> is a trifluoromethyl group. 30. Estratrienes according to Claim 28, in which R<17> is a methyl group. 31. Estratrienes according to Claim 28, in which R<17> is a hydrogen atom. 32. Estratrienes according to Claim 1, in which R<17> is in &beta;-position. 33. Estratrienes according to Claim 32, in which R<17> is a methyl group. 34. Estratrienes according to Claim 32, in which R<17> is a hydrogen atom. 35. Estratrienes according to Claim 28, in which R<14> and R<17> together form an ethano bridge. 36. Estratrienes according to Claim 1, in which SK is a radical of partial formula with x=0, 1 or 2. 37. Estratrienes according to Claim 13, in which m=5, E is a perfluoroethyl radical and the conformation of the 2-carbon atom of the heterocycle is R. 38. Estratrienes according to Claim 13, in which m=5, E is a perfluoroethyl radical and the conformation of the 2-carbon atom of the heterocycle is S. 39. Estratrienes according to Claim 37, in which R<17> is in &alpha;-position and is a hydrogen atom. 40. Estratrienes according to Claim 1, namely 14,17-ethano-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 14,17-ethano-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfinyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 3,17&beta;-diacetoxy-14&alpha;,17&alpha;-ethano-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene, 14,17-ethano-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfonyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 17&alpha;-trifluoromethyl-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 15&beta;,16&beta;-methano-17&alpha;-methyl-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 15&beta;,16&beta;-methano-17&alpha;-methyl-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfinyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 15&beta;,16&beta;-methano-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 15&beta;,16&beta;-methano-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfinyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 15&beta;-methyl-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 15&beta;,17&alpha;-dimethyl-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 11&beta;-fluoro-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 11&beta;-fluoro-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfinyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 11&beta;-fluoro-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfonyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 16&alpha;-fluoro-17&alpha;-methyl-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 16&alpha;-fluoro-17&beta;-methyl-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&alpha;-diol, 16&alpha;-fluoro-17&alpha;-methyl-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfinyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 16&alpha;-fluoro-17&alpha;-methyl-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfonyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 16&alpha;-fluoro-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 16&alpha;-fluoro-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&alpha;-diol, 16&alpha;-fluoro-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfinyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 16&alpha;-fluoro-7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfonyl)propylamino]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentylthio)propylamino]pentyl}estra-1,3,5(10),14-tetraene-3,17&beta;-diol, 7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfinyl)propylamino]pentyl}estra-1,3,5(10),14-tetraene-3,17&beta;-diol, 7&alpha;-{5-[N-methyl-N-3-(4,4,5,5,5-pentafluoropentanesulfonyl)propylamino]pentyl}estra-1,3,5(10),14-tetraene-3,17&beta;-diol, 7&alpha;-{5-[(2S)-2-(4,4,5,5,5-pentafluoropentylthiomethyl)pyrrolidin-1-yl]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 7&alpha;-{5-[(2R)-2-(4,4,5,5,5-pentafluoropentylthiomethyl)pyrrolidin-1-yl]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 17&alpha;-methyl-7&alpha;-{5-[2-(4,4,5,5,5-pentafluoropentylthiomethyl)pyrrolidin-1-yl]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 11&beta;-fluoro-7&alpha;-{5-[2-(4,4,5,5,5-pentafluoropentylthiomethyl)pyrrolidin-1-yl]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 11&beta;-fluoro-17&alpha;-methyl-7&alpha;-{5-[(2S)-2-(4,4,5,5,5-pentafluoropentylthiomethyl)pyrrolidin-l-yl]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 11&beta;-fluoro-17&alpha;-methyl-7&alpha;-{5-[(2S)-2-(4,4,5,5,5-pentafluoropentanesulfinylmethyl)pyrrolidin-1-yl]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 11&beta;-fluoro-17&alpha;-methyl-7&alpha;-{5-[(2S)-2-(4,4,5,5,5-pentafluoropentanesulfonylmethyl)pyrrolidin-1-yl]pentyl}estra-1,3,5(10)-triene-3,17&beta;-diol, 7 &alpha;-{5-[(2S)-2-(4,4,5,5,5-p
申请公布号 EA001577(B1) 申请公布日期 2001.06.25
申请号 EA19990000210 申请日期 1997.08.20
申请人 SCHERING AKTIENGESELLSCHFT 发明人 BOLHMANN, ROLF;BITTLER, DIETER;HEINDI, JOSEF;HEINRICH, NIKOLAUS;HOFMEISTER, HELMUT;KUNZER, HERMANN;SAUER, GERHARD;HEGELE-HARTUNG, CHRISTA;LICHTNER, ROMEMARIE;NISHINO, YUKISHIGE;PARCZYK, KARSTEN;SCHNEIDER, MARTIN
分类号 A61K31/565;A61K31/58;A61P5/32;C07J41/00;C07J43/00;C07J53/00 主分类号 A61K31/565
代理机构 代理人
主权项
地址